Dr Reddy's Laboratories’ Andhra Pradesh plant gets two observations from USFDA

08 Jul 2022 Evaluate

United States Food & Drug Administration (USFDA) has completed a Pre-Approval Inspection (PAI) and issued Form 483 with two observations to Dr. Reddy's Laboratories. The USFDA issued observations after inspecting the company’s manufacturing facility FTO 11 located at Srikakulam in Andhra Pradesh. The inspection was conducted from June 30, 2022 to July 07, 2022. The company will address this within the stipulated timeline.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1318.90 12.30 (0.94%)
26-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1784.60
Dr. Reddys Lab 1318.90
Cipla 1357.80
Zydus Lifesciences 938.15
Lupin 2323.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×